A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/199
A61K 31/70 (2006.01) A61K 31/35 (2006.01) A61K 31/715 (2006.01) C08B 37/00 (2006.01) C12N 9/99 (2006.01)
Patent
CA 2018133
- 1 - BEHRINGWERKE AKTIENGESELLSCHAFT 89/B 024 - Ma 730 Dr. Ha/Sd Abstract of the disclosure The use of xylan polyhydrogensulfates for the therapy of disorders based on cell proliferation The use of compounds of the formula I Image I in which n is an integer from 1 to 20, preferably 8 to 10, especially 9, or of mixtures with a mean molecular weight of about 1,000 to 20,000 Dalton, preferably of about 5,000 to 12,000 Dalton, especially about 6,000 Dalton (? = 9), or of one of the pharmacologically acceptable acid addition salts thereof, for the prepara- tion of a pharmaceutical for the therapy of disorders based on uncontrolled and undifferentiated cell growth, is described.
Czech Jorg
Dickneite Gerhard
Larocca Renato V.
Myers Charles E.
Schrinner Elmar
Behringwerke Aktiengesellschaft
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Czech Jorg
Dickneite Gerhard
Larocca Renato V.
LandOfFree
Use of xylan polyhydrogensulfates for the therapy of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of xylan polyhydrogensulfates for the therapy of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of xylan polyhydrogensulfates for the therapy of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1618880